Skip to content

Efficacy trial of single intake of plant derived ingredient. [n2019005]

Efficacy trial of single intake of plant derived ingredient. [n2019005] - Efficacy of plant derived ingredient [n2019005]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037243
Enrollment
18
Registered
2019-07-03
Start date
2019-04-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1)Healthy male (2)Adult aged from 20 y to 65 y (3)The person who can participate on the scheduled day (4)The person who can consume test foods, and record habitual lifestyle and diets (5)The person who have given written informed consent prior to the study

Exclusion criteria

Exclusion criteria: (1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) Having history or presence of cardiovascular disease or cerebrovascular disease (4) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (5) Having history of resection of gastrointestinal tract (6) Thyroid deficiency (7) Heavy alcohol drinker (over 30g per day) (8) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study (9) Collected 200 mL of blood within the last 1 month or 400 mL within the last 3 months (10) Severe anemia (Hb <=7g/dL) (11) Feeling sick due to blood collection (12) Having thin blood vessels (13) Food allergies for test foods (14) Cannot take all of the test food (15) Planning long-term trips or business trips (16) Intaking the healthy food that affect glucose metabolism (17) Planned to participate in other clinical study during current study (18) Determined to be unqualified by the physician in charge or the responsible person of the study

Design outcomes

Primary

MeasureTime frame
Postprandial blood GLP-1 concentration

Secondary

MeasureTime frame
Postprandial blood concentration of glucose, insulin and GIP

Countries

Japan

Contacts

Public ContactAya Yanagimoto

Kao Corporation Biological Science Research laboratories

yanagimoto.aya@kao.com03-5630-7476

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026